Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
lncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis
Zhenchang Wang1, DanDan Huang2, Jingjing Huang3
1Department of Spleen and Stomach Liver Disease, International Zhuang Hospital District of Guangxi University of Chinese Medicine, Nanning, Guangxi, People's Republic of China.
Background:
Previous evidence have shown that long non-coding RNA (lncRNA) TMPO antisense RNA 1 (TMPO-AS1) is involved in the aggressiveness of several cancers. Nevertheless, the precise functions of TMOP-AS1 in hepatocellular carcinoma (HCC) are still unresolved.
Materials And Methods:
The expressions of TMPO-AS1 and miR-320a were detected in HCC tissues and cells by qRT-RCR. The cell growth, migration and invasion were detected by colony formation, wound healing assay and Transwell assay, respectively. The targeting relation between miR-320a and TMPO-AS1 was predicted by bioinformatics analysis and identified by luciferase reporter gene as well as FISH assay. The expression of SERPINE1 MRNA Binding Protein 1 (SERBP1) was detected by Western blot. The growth of HCC cell was analyzed using transplanted tumor model.
Results:
Currently, we revealed that TMPO-AS1 was overexpressed in clinical HCC samples and a panel of HCC cell lines. Clinically, a higher level of TMPO-AS1 was connected to the advanced stage of HCC and worse prognosis of patients. Depletion of TMPO-AS1 repressed HCC cell viability, migration ability and invasiveness. Nevertheless, upregulation of TMPO-AS1 caused opposite results. Further studies revealed that lncRNA TMPO-AS1 was largely located in the cytoplasm of HCC cell and sponge miR-320a, resulting in increasing the level of SERBP1 in HCC cell. Finally, TMPO-AS1 silencing suppressed tumor growth of HCC cell in vivo.
Conclusion:
Collectively, our results suggested that TMPO-AS1 was a promoting factor for the aggressive behaviors of HCC cell.
Insights
Long non-coding RNA TMPO-AS1 promotes hepatocellular carcinoma (HCC) aggressiveness by sponging miR-320a, increasing SERBP1 levels, and driving tumor growth. This study clarifies TMPO-AS1
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA (lncRNA) TMPO-AS1 is implicated in various cancers' aggressiveness.
- The specific role of TMPO-AS1 in hepatocellular carcinoma (HCC) remains unclear.
Purpose of the Study:
- To investigate the function and mechanism of TMPO-AS1 in HCC.
- To determine the relationship between TMPO-AS1, miR-320a, and SERBP1 in HCC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for TMPO-AS1 and miR-320a expression.
- Cell viability, migration, and invasion assays (colony formation, wound healing, Transwell).
- Bioinformatics, luciferase reporter, and FISH assays for molecular interactions.
- Western blot for SERBP1 expression and in vivo tumor growth models.
Main Results:
- TMPO-AS1 is overexpressed in HCC tissues and cell lines, correlating with advanced stage and poor prognosis.
- TMPO-AS1 depletion inhibits HCC cell viability, migration, and invasion; upregulation has opposite effects.
- TMPO-AS1 acts as a sponge for miR-320a in the cytoplasm, increasing SERBP1 levels and promoting tumor growth in vivo.
Conclusions:
- TMPO-AS1 promotes aggressive behaviors in hepatocellular carcinoma.
- TMPO-AS1 functions by regulating the miR-320a/SERBP1 axis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
